FGF8 promotes cell proliferation and resistance to EGFR inhibitors via upregulation of EGFR in human hepatocellular carcinoma cells
Authors:
Open Access
- 1 April 2017
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 38 (4) , 2205-2210
Abstract
Fibroblast growth factor 8 (FGF8), a member of the fibroblast growth factor (FGF) family, is upregulated in several human cancers, including HCC (HCC). Previous studies have demonstrated that FGF8 increased cell growth and invasion of tumor cells. In the present study we investigated whether FGF8 is involved in the cell proliferation and resistance to several drugs in human HCC cells. We stably overexpressed FGF8 by lentiviral transfection. In addition, we also added recombinant FGF8 instead of stably overexpressing FGF8 in human HCC cells. Stable overexpression of FGF8 or exogenous recombinant FGF8 resulted in significantly enhanced cell proliferation in human HCC cells. With the use of CellTiter-Glo assay for the determination of cell viability, we found that FGF8 increased the resistance to epidermal growth factor receptor (EGFR) inhibitors in human HCC cells. Additionally, the expression of EGFR was also upregulated by stably overexpressing FGF8 or exogenous recombinant FGF8. Yes-associated protein 1 (YAP1) was reported to upregulate the expression of EGFR. Moreover, we also found that FGF8 increased the expression of YAP1 and knockdown of YAP1 eliminated the upregulation of EGFR and the resistance to EGFR inhibition induced by FGF8. Our study provides evidence that FGF8 plays an important role in the resistance to EGFR inhibition of human HCC cells.Keywords
This publication has 40 references indexed in Scilit:
- Fibroblast Growth Factor 8 Expression in GT1-7 GnRH-Secreting Neurons Is Androgen-Independent, but Can Be Upregulated by the Inhibition of DNA MethyltransferasesFrontiers in Cell and Developmental Biology, 2016
- Expression of functional recombinant human fibroblast growth factor 8b and its protective effects on MPP+-lesioned PC12 cellsApplied Microbiology and Biotechnology, 2015
- FGF8 promotes colorectal cancer growth and metastasis by activating YAP1Oncotarget, 2014
- The Hippo signaling pathway in stem cell biology and cancerEMBO Reports, 2014
- Fibroblast growth factor signaling in liver carcinogenesisHepatology, 2013
- The Hippo–YAP pathway in organ size control and tumorigenesis: an updated versionGenes & Development, 2010
- Fibroblast growth factor signalling: from development to cancerNature Reviews Cancer, 2010
- Fibroblast Growth Factors: Biology, Function, and Application for Tissue RegenerationJournal of Tissue Engineering, 2010
- Cooperation between FGF8b Overexpression and PTEN Deficiency in Prostate TumorigenesisCancer Research, 2006
- FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent diseaseOncogene, 1999